Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

$75 Million In Funding And Nearly $200 Million In Annual Revenue

researchsnappy by researchsnappy
September 13, 2020
in Advertising Research
0
$75 Million In Funding And Nearly $200 Million In Annual Revenue
399
SHARES
2.3k
VIEWS
Share on FacebookShare on Twitter

  • Truepill — a healthcare services company that is known for offering telehealth and pharmacy fulfillment — made a couple of major announcements this week. These are the details.

Truepill — a healthcare services company that is known for offering telehealth and pharmacy fulfillment — made a couple of major announcements this week. The company said it was launching an at-home medical testing service to facilitate products offered by companies like Hims and Hers, Nurx, and GoodRx. And the company also announced a new $75 million round of funding led by Oak HC/FT with participation from Optum Ventures, TI Platform Management, Sound Ventures and Y Combinator.

“With the change in reimbursement for telemedicine, it changed the trajectory of the direct to consumer companies,” said Annie Lamont, the co-founder and managing director of new lead investors Oak HC/FT via TechCrunch. “When we talked to every one of them they all seemed to be using Truepill .”

Interestingly, Truepill’s co-founders Umar Afridi and Sid Viswanathan met through LinkedIn when Viswanathan cold-emailed Afridi. During that time, Afridi was working as a pharmacist filling prescriptions at a Fred Meyer location near Seattle.

Truepill’s growth originally began by acting as a pharmacist to companies like Hims, Nurx, and other several other direct-to-consumer healthcare companies. Through these relationships, Truepill is on track to hit $200 million in revenue. Along with direct-to-consumer companies, Truepill’s customers also include insurance companies and healthcare providers.

“Everything we do is white labeled from our pharmacy to the lab testing component. You can go to teladoc and use that service… We like to think early. 80% of healthcare is going to happen on a digital channel. We’re in a perfect position to build the platform company in that space,” said Viswanathan via TechCrunch.

The at-home testing service that will be offered by Truepill by the end of the year will be powered through the company’s relationships with lab testing providers. Truepill is going to focus on the tests that manages chronic conditions such as heart disease, diabetes, and kidney disease.

“To create a comprehensive, effective digital healthcare experience, there are three essential pillars: pharmacy with extensive insurance coverage, at-home lab testing, and telehealth,” added Viswanathan. “By adding diagnostics to our suite of solutions, we’ll be able to deliver direct-to-patient healthcare at scale through one platform – Truepill. We envision a future where 80% of healthcare is digital. With diagnostics, telehealth and pharmacy built on our foundation of API-connected infrastructure, Truepill will power that reality.”

 

Previous Post

COVID Baking Boom Boosts Egg Carton Demand

Next Post

September Girl Group Brand Reputation Rankings Announced

Next Post
September Girl Group Brand Reputation Rankings Announced

September Girl Group Brand Reputation Rankings Announced

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News
  • Top Company News

HPIN International Financial Platform Becomes a New Benchmark for India’s Digital Economy

Top 10 Market Research Companies in the world

3 Best Market Research Certifications in High Demand

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2025 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2025 researchsnappy.com